• Explore /
  • Poster
  • / Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1).

Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1).

Abstract Poster

Authors

Marijo Bilusic

Marijo Bilusic

National Cancer Institute, Bethesda, MD

Marijo Bilusic , Matthew R. Zibelman , Pooja Ghatalia , Susan Wroblewski , Ravi Amrit Madan , Fatima Karzai , William L. Dahut , James L. Gulley , Elizabeth R. Plimack , Daniel M. Geynisman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02614859

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 85)

Abstract #

85

Poster Bd #

D9

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

First Author: Marijo Bilusic

First Author: Alan Dal Pra

First Author: Alan Dal Pra

First Author: Michael J. Morris